Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00271089 · ClinicalTrials.gov registry record · NA
Blood Cell Collection for Future Use in Individuals With Fanconi Anemia
A NA study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00271089 is a NA study that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 40 participants.
The verdict
NCT00271089, a NA study, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Fanconi anemia (FA) is a disease that affects an individual's bone marrow. It is caused by a defective gene in the CD34+ cells, which are responsible for producing various types of blood cells. Individuals with FA may experience fatigue, bleeding, and increased infections. The purpose of this study is to collect and purify blood cells from individuals with FA and store them for future therapeutic use.
Interventions
- PROCEDURE PBSC Collection
- PROCEDURE Bone Marrow Harvest
- DEVICE CliniMacs Cell Selection System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-08 |
| Est. Completion | 2007-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00271089
The ClinicalTrials.gov registry entry for NCT00271089 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PBSC Collection is the first listed.
NCT00271089 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00271089 about?
NCT00271089 is a clinical study titled "Blood Cell Collection for Future Use in Individuals With Fanconi Anemia". Fanconi anemia (FA) is a disease that affects an individual's bone marrow. It is caused by a defective gene in the CD34+ cells, which are responsible for producing various types of blood cells. Individuals with FA may experience fatigue, bleeding, and increased infections. The purpose of this study ...
What is the current status of trial NCT00271089?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2004-08. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00271089?
The interventions under investigation include: PBSC Collection (PROCEDURE), Bone Marrow Harvest (PROCEDURE), CliniMacs Cell Selection System (DEVICE).
Who is sponsoring clinical trial NCT00271089?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.